BBC3 and colorectal carcinoma: Chen et al.56 reported that regorafenib treatment enhances PUMA expression in HCT116, Lim2405, LoVo, Lim1215, SW48, and RKI CRC cells in a dose- and time-dependent manner and in xenograft tumors; moreover, this effect correlated with apoptosis induction.